Press "Enter" to skip to content

New patent expiration for Merck Sharp drug CLARINEX

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Merck Sharp drug CLARINEX

Annual Drug Patent Expirations for CLARINEX
Annual Drug Patent Expirations for CLARINEX

Clarinex is a drug marketed by Merck Sharp Dohme and is included in five NDAs. It is available from one supplier. There are eight patents protecting this drug and four Paragraph IV challenges.

Drug patent litigation for CLARINEX.

The generic ingredient in CLARINEX is desloratadine; pseudoephedrine sulfate. One supplier is listed for this compound. Additional details are available on the desloratadine; pseudoephedrine sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Merck Sharp drug CLARINEX
    Do NOT follow this link or you will be banned from the site!